1Sarasua SM, Mueller P, Kathman S, et al. Confirming the utility of four kidney biomarker tests in a longitudinal follow-up study. Ren Fail, 2003 ,25:797-817.
2Greive KA, Eppel GA, Reeve S,et al. Immuno-unreactive albumin excretion increases in streptozotocin diabetic rats. Am J of Kidney Dis, 2001,38:144-152.
3Comper WD, Osicka TM, Jerums G. High prevalence of immuno-unreactive intact albumin in the urine of diabetic patients. Am J Kid Dis, 2003,41:336-342.
4Caramori ML, Fioretto P, Mauer M. Long-term follow-up of normoalbuminuric long-standing type 1 diabetic patients: progression is associated with worse baseline glomerular lesions and lower glomerular filtration rate (Abstract). J Am Soc Nephrol, 1999,10:126A.
5Westhuyzen J, Endre ZH, Reece G, et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant,2003, 18:543-551.
6Salem MA, el-Habashy SA, Saeid OM ,et al. Urinary excretion of N-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Pediatr Diabetes, 2002,3:37-41.
7Massey D. Commentary: clinical diagnostic use of cystatin C. J Clin Lab Anal, 2004,18:55-60.
8Bernard A, Lauwerys R. Low-molecular -weight proteins as markers of organ toxicity with special reference to Clara cell protein. Toxicol Lett,1995 ,77: 145-151.
9Perilloux BC,Shetty AK,Leiva LE,et al. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study. Clinical Rheumatology, 2000,19: 200-203.
10Westman KW,Bygren PG ,Eilert I,et al. Rapid screening assay for anti-GBM antibody and ANCAs:an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrology Dialysis Transplantation,1997,12:1863-1868.
